CIK 0001613103 · Large accelerated filer
Medtronic plc
Sign in to watch- Ticker
- MDT
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Apr 24
- Entity type
- operating
- Phone
- 01135314381700
- Business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland, H91 4K49
- Former names
- Medtronic Ltd, Medtronic Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,889,203
- in 3 filings, $5.8M under 10b5-1 plans
Net −$5,889,203. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Walter Matthew R. SVP, Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +40,973 | 40,973 | ||
| 2026-08-03 | Marinaro Michael EVP, Pres MedSurg and Americas | Grant or award | +10,960 | 71,273 | ||
| 2026-08-03 | Marinaro Michael EVP, Pres MedSurg and Americas | Grant or award | +46,147 | 117,420 | ||
| 2026-08-03 | Marinaro Michael EVP, Pres MedSurg and Americas | Grant or award · Performance Share Units | +27,400 | 27,400 | ||
| 2026-08-03 | Marinaro Michael EVP, Pres MedSurg and Americas | Grant or award · Stock Option (Right to Buy) | +77,848 | 77,848 | ||
| 2026-08-03 | Quinn Michelle EVP, GC and Secretary | Grant or award | +6,346 | 26,721 | ||
| 2026-08-03 | Quinn Michelle EVP, GC and Secretary | Grant or award · Performance Share Units | +15,863 | 15,863 | ||
| 2026-08-03 | Quinn Michelle EVP, GC and Secretary | Grant or award · Stock Option (Right to Buy) | +45,070 | 45,070 | ||
| 2026-08-03 | KIIL HARRY SKIP EVP & President Cardiovascular | Grant or award | +9,230 | 43,669 | ||
| 2026-08-03 | KIIL HARRY SKIP EVP & President Cardiovascular | Grant or award · Performance Share Units | +23,074 | 23,074 | ||
| 2026-08-03 | KIIL HARRY SKIP EVP & President Cardiovascular | Grant or award · Stock Option (Right to Buy) | +65,556 | 65,556 | ||
| 2026-08-03 | Martha Geoffrey Chairman and CEO | Grant or award | +41,533 | 327,866 | ||
| 2026-08-03 | Martha Geoffrey Chairman and CEO | Grant or award · Performance Share Units | +103,831 | 103,831 | ||
| 2026-08-03 | Martha Geoffrey Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +295,002 | 295,002 | ||
| 2026-08-03 | Martha Geoffrey Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +273,150 | 273,150 | ||
| 2026-07-31 | Thompson Kweli EVP & President, Neuroscience | Shares withheld for taxes | −1,739 | $85.39 | $148K | 28,467 |
| 2026-07-31 | Blomquist Denise L. Chief Accounting Officer | Shares withheld for taxes | −212 | $85.39 | $18K | 14,661 |
| 2026-07-31 | Walter Matthew R. SVP, Chief HR Officer | Shares withheld for taxes | −1,675 | $85.39 | $143K | 34,159 |
| 2026-07-31 | Marinaro Michael EVP, Pres MedSurg and Americas | Shares withheld for taxes | −3,356 | $85.39 | $287K | 60,313 |
| 2026-07-31 | KIIL HARRY SKIP EVP & President Cardiovascular | Shares withheld for taxes | −3,074 | $85.39 | $262K | 34,439 |
Page 2 of 12 · 239 trades